This Global Report Series represents iData’s entire collection of country-level reports in the Global Dental Bone Graft Substitute market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s publication year: United States (2021) Europe (2021) China (2021) South

In 2021, the US dental bone graft substitutes (DBGS) market size is expected to reach $390 million, with the Allograft market showing the fastest growth. Despite COVID19, the US market size is expected to increase over the forecast period to exceed $540 million in 2027. Over 40% of the dental bone graft substitutes market share

The full report suite on the European market for dental bone graft substitutes (DBGSs) and other biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes (DBMs).

In 2021, the Argentina dental bone graft substitutes (DBGS) market size is projected to reach $2.2 million, with the Synthetic Bone Graft market showing the highest growth. In spite of COVID19, the Argentinian market size is expected to increase over the forecast period to exceed $4.8 million in 2027.

In 2021, the Brazil dental bone graft substitutes (DBGS) market size is projected to reach $58 million, with the Synthetic Bone Graft market showing the highest growth. In spite of COVID19, the Brazilian market size is expected to increase over the forecast period to exceed $133 million in 2027.

In 2021, the Mexico dental bone graft substitutes (DBGS) market size is projected to reach $12 million, with the Synthetic Bone Graft market showing the highest growth. In spite of COVID19, the Mexican market size is expected to increase over the forecast period to exceed $23 million in 2027.

In 2021, Australia’s dental bone graft substitutes (DBGS) market size is projected to reach $39 million, with the Demineralized Bone Matrix (DBM) Allograft market showing the highest growth. In spite of COVID19, the Australian market size is expected to increase over the forecast period to exceed $83 million in 2027.

In 2021, the China dental bone graft substitutes (DBGS) market size is projected to reach $146 million, with the Allograft and Xenograft markets showing the highest growth. In spite of COVID19, the Chinese market size is expected to increase with a compound annual growth rate of 28.8% to exceed an astounding $389 million in 2027.

In 2021, the India dental bone graft substitutes (DBGS) market size is projected to reach $19 million, with the Xenograft market showing the highest growth. In spite of COVID19, the Indian market size is expected to increase with a compound annual growth rate of 27.8% to reach $52 million in 2027. The most impactful factor

In 2021, the Japan dental bone graft substitutes (DBGS) market size is projected to reach $20.7 million, with the Xenograft market showing the highest growth. In spite of COVID19, the Japanese market size is expected to increase over the forecast period to exceed $34 million in 2027. The total Japanese dental bone graft substitutes market

In 2021, the South Korea dental bone graft substitutes (DBGS) market size is projected to reach $71 million, with the Xenograft market showing the highest growth. In spite of COVID19, the South Korean market size is expected to increase at a compound annual growth rate of 11.7% to exceed $109 million in 2027. An ongoing trend

The full report suite on the U.S. market for dental bone graft substitutes (DBGS) and other biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes.

Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.

Dental growth factor and tissue engineering products is a broad category that encompasses products used for facilitating and enhancing bone regeneration. This includes growth factors and enamel matrix protein solutions. Platelet rich plasma (PRP) is also used for these purposes, but will not be considered within this report.

Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.

Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.